RVL Pharmaceuticals plc
SEC CIK 1739426 · RVLP · last insider filing 2023-10-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lask Alisa | Director | filed 2022 - 2023 |
| Cowan Gregory L | Director | filed 2019 - 2023 |
| Debiasi Michael J. | Director | filed 2019 - 2023 |
| Burgstahler David F | Director | filed 2018 - 2023 |
| Venkataraman Sriram | Director | filed 2018 - 2023 |
| Markison Brian A | Director · Chief Executive Officer | filed 2018 - 2022 |
| Weiss Fred G | Director | filed 2018 - 2021 |
| Vergez Juan Augusto | Director | filed 2018 - 2018 |
| Sielecki Carlos Alberto | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schaub James | EVP and COO | filed 2018 - 2023 |
| Klein Christopher | General Counsel and Secretary | filed 2018 - 2023 |
| Devries Tina Marie | EVP, Research & Development | filed 2018 - 2022 |
| Depetris Michael | Principal Accounting Officer | filed 2022 - 2022 |
| Einhorn Andrew J. | Chief Financial Officer | filed 2018 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.